CN102311355A - 罗本考昔的一种制备方法 - Google Patents
罗本考昔的一种制备方法 Download PDFInfo
- Publication number
- CN102311355A CN102311355A CN201110286563A CN201110286563A CN102311355A CN 102311355 A CN102311355 A CN 102311355A CN 201110286563 A CN201110286563 A CN 201110286563A CN 201110286563 A CN201110286563 A CN 201110286563A CN 102311355 A CN102311355 A CN 102311355A
- Authority
- CN
- China
- Prior art keywords
- benkao
- luo
- former times
- adopting
- acidylate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- RZJQGNCSTQAWON-UHFFFAOYSA-N rofecoxib Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=C(C=2C=CC=CC=2)C(=O)OC1 RZJQGNCSTQAWON-UHFFFAOYSA-N 0.000 title abstract 4
- 229960000371 rofecoxib Drugs 0.000 title abstract 4
- 238000000034 method Methods 0.000 claims abstract description 23
- 125000005266 diarylamine group Chemical group 0.000 claims abstract description 13
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 8
- 230000005494 condensation Effects 0.000 claims abstract description 8
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 8
- 230000008707 rearrangement Effects 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 238000005917 acylation reaction Methods 0.000 claims abstract description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000002904 solvent Substances 0.000 claims description 11
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 7
- 238000009833 condensation Methods 0.000 claims description 7
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 7
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 6
- 230000007062 hydrolysis Effects 0.000 claims description 6
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 6
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 6
- 238000007363 ring formation reaction Methods 0.000 claims description 6
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- -1 halogen acid amide Chemical class 0.000 claims description 5
- 235000015320 potassium carbonate Nutrition 0.000 claims description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- UAIZDWNSWGTKFZ-UHFFFAOYSA-L ethylaluminum(2+);dichloride Chemical compound CC[Al](Cl)Cl UAIZDWNSWGTKFZ-UHFFFAOYSA-L 0.000 claims description 3
- 239000002841 Lewis acid Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 2
- 150000007517 lewis acids Chemical class 0.000 claims description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 238000005516 engineering process Methods 0.000 abstract description 4
- 230000029936 alkylation Effects 0.000 abstract description 3
- 238000005804 alkylation reaction Methods 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- HRXZRAXKKNUKRF-UHFFFAOYSA-N 4-ethylaniline Chemical compound CCC1=CC=C(N)C=C1 HRXZRAXKKNUKRF-UHFFFAOYSA-N 0.000 abstract 2
- 230000010933 acylation Effects 0.000 abstract 2
- SPSWJTZNOXMMMV-UHFFFAOYSA-N 2,3,5,6-tetrafluoroaniline Chemical compound NC1=C(F)C(F)=CC(F)=C1F SPSWJTZNOXMMMV-UHFFFAOYSA-N 0.000 abstract 1
- PBYIIRLNRCVTMQ-UHFFFAOYSA-N 2,3,5,6-tetrafluorophenol Chemical compound OC1=C(F)C(F)=CC(F)=C1F PBYIIRLNRCVTMQ-UHFFFAOYSA-N 0.000 abstract 1
- 238000006482 condensation reaction Methods 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 238000006462 rearrangement reaction Methods 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 16
- 239000000243 solution Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 4
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 3
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 102100038277 Prostaglandin G/H synthase 1 Human genes 0.000 description 2
- 108050003243 Prostaglandin G/H synthase 1 Proteins 0.000 description 2
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000002524 organometallic group Chemical group 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- ODIGIKRIUKFKHP-UHFFFAOYSA-N (n-propan-2-yloxycarbonylanilino) acetate Chemical compound CC(C)OC(=O)N(OC(C)=O)C1=CC=CC=C1 ODIGIKRIUKFKHP-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 108010037462 Cyclooxygenase 2 Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000010813 municipal solid waste Substances 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N pentanoic acid group Chemical group C(CCCC)(=O)O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000002512 suppressor factor Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110286563.8A CN102311355B (zh) | 2011-09-26 | 2011-09-26 | 罗本考昔的一种制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110286563.8A CN102311355B (zh) | 2011-09-26 | 2011-09-26 | 罗本考昔的一种制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102311355A true CN102311355A (zh) | 2012-01-11 |
CN102311355B CN102311355B (zh) | 2014-02-05 |
Family
ID=45424961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110286563.8A Active CN102311355B (zh) | 2011-09-26 | 2011-09-26 | 罗本考昔的一种制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102311355B (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103130594A (zh) * | 2012-07-30 | 2013-06-05 | 浙江大学 | 从酚类化合物出发制备n-芳基和n-烷基芳胺类化合物方法 |
CN104119266A (zh) * | 2013-04-25 | 2014-10-29 | 浙江大学 | 从酚类化合物出发制备咔唑的方法 |
CN107721901A (zh) * | 2017-11-12 | 2018-02-23 | 刘磊 | 一种2‑[2‑(2,3,5,6‑四氟苯胺基)苯基]乙酸的制备方法 |
CN109503399A (zh) * | 2018-12-29 | 2019-03-22 | 江苏天和制药有限公司 | 一种罗本考昔的制备方法 |
CN109694330A (zh) * | 2017-10-24 | 2019-04-30 | 乳源瑶族自治县东阳光生物科技有限公司 | 一种酸的制备方法 |
CN110437090A (zh) * | 2019-07-31 | 2019-11-12 | 江苏天和制药有限公司 | 一种罗本考昔三聚体及其制备方法 |
WO2020021077A1 (en) | 2018-07-27 | 2020-01-30 | Krka, D.D., Novo Mesto | A process for the preparation of polymorphic form of robenacoxib |
CN111807978A (zh) * | 2020-07-29 | 2020-10-23 | 武汉川泰科技有限公司 | 一种罗贝考昔的制备方法 |
CN112679410A (zh) * | 2019-10-17 | 2021-04-20 | 东莞市东阳光动物保健药品有限公司 | 一种罗本考昔中间体的制备方法 |
CN115108926A (zh) * | 2022-04-02 | 2022-09-27 | 上海工程技术大学 | 一种用于制备厄达替尼的中间体化合物及制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1268112A (zh) * | 1997-08-28 | 2000-09-27 | 诺瓦提斯公司 | 某些5-烷基-2-芳基氨基苯乙酸及其衍生物 |
US20090275758A1 (en) * | 1999-09-27 | 2009-11-05 | Murat Acemoglu | Process for phenylacetic acid derivatives |
-
2011
- 2011-09-26 CN CN201110286563.8A patent/CN102311355B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1268112A (zh) * | 1997-08-28 | 2000-09-27 | 诺瓦提斯公司 | 某些5-烷基-2-芳基氨基苯乙酸及其衍生物 |
US20090275758A1 (en) * | 1999-09-27 | 2009-11-05 | Murat Acemoglu | Process for phenylacetic acid derivatives |
Non-Patent Citations (2)
Title |
---|
DEMIEN BARBARAS等: "Removal of Heavy Metals from Organic Reaction Mixtures Preparation and Application of Functionalized Resins", 《ORGANIC PROCESS RESEARCH & DEVELOPMENT》 * |
MURAT ACEMOGLU: "Synthesis of new N-aryl oxindoles as intermediates for pharmacologically active compounds", 《TETRAHEDRON》 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103130594A (zh) * | 2012-07-30 | 2013-06-05 | 浙江大学 | 从酚类化合物出发制备n-芳基和n-烷基芳胺类化合物方法 |
CN104119266A (zh) * | 2013-04-25 | 2014-10-29 | 浙江大学 | 从酚类化合物出发制备咔唑的方法 |
CN109694330A (zh) * | 2017-10-24 | 2019-04-30 | 乳源瑶族自治县东阳光生物科技有限公司 | 一种酸的制备方法 |
CN109694330B (zh) * | 2017-10-24 | 2023-10-20 | 乳源瑶族自治县东阳光生物科技有限公司 | 一种酸的制备方法 |
CN107721901A (zh) * | 2017-11-12 | 2018-02-23 | 刘磊 | 一种2‑[2‑(2,3,5,6‑四氟苯胺基)苯基]乙酸的制备方法 |
WO2020021077A1 (en) | 2018-07-27 | 2020-01-30 | Krka, D.D., Novo Mesto | A process for the preparation of polymorphic form of robenacoxib |
CN109503399A (zh) * | 2018-12-29 | 2019-03-22 | 江苏天和制药有限公司 | 一种罗本考昔的制备方法 |
CN109503399B (zh) * | 2018-12-29 | 2021-12-24 | 江苏天和制药有限公司 | 一种罗本考昔的制备方法 |
CN110437090A (zh) * | 2019-07-31 | 2019-11-12 | 江苏天和制药有限公司 | 一种罗本考昔三聚体及其制备方法 |
CN112679410A (zh) * | 2019-10-17 | 2021-04-20 | 东莞市东阳光动物保健药品有限公司 | 一种罗本考昔中间体的制备方法 |
CN111807978A (zh) * | 2020-07-29 | 2020-10-23 | 武汉川泰科技有限公司 | 一种罗贝考昔的制备方法 |
CN111807978B (zh) * | 2020-07-29 | 2023-03-14 | 武汉川泰科技有限公司 | 一种罗贝考昔的制备方法 |
CN115108926A (zh) * | 2022-04-02 | 2022-09-27 | 上海工程技术大学 | 一种用于制备厄达替尼的中间体化合物及制备方法 |
CN115108926B (zh) * | 2022-04-02 | 2023-06-20 | 上海工程技术大学 | 一种用于制备厄达替尼的中间体化合物及制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102311355B (zh) | 2014-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102311355A (zh) | 罗本考昔的一种制备方法 | |
CN113527272B (zh) | 一种特戈拉赞的合成方法 | |
CN103420893B (zh) | 制备西洛多辛中间体的方法 | |
CN102746210A (zh) | 一种西洛多辛关键中间体的合成方法 | |
CN106008290A (zh) | 一种环磺酮的制备方法 | |
CN103664923A (zh) | 硝呋太尔的制备方法 | |
JP2013234194A (ja) | C−グリコシド誘導体の製造方法 | |
CN113717053A (zh) | 一种酪氨酸激酶抑制剂关键中间体的合成方法 | |
CN104098540B (zh) | 一种制备扎托布洛芬的方法 | |
CN103992241B (zh) | N-取代苯基甘氨酸的制备方法 | |
CN104672180B (zh) | 一种[(1s)‑3‑甲基‑1‑[[(2r)‑2‑甲基环氧乙基]羰基]丁基]氨基甲酸叔丁酯的手性制备方法 | |
CN107325078B (zh) | 一种西洛他唑的制备方法 | |
CN105348197A (zh) | 一种盐酸绿卡色林的制备方法 | |
CN104003903B (zh) | 沙坦联苯的合成方法 | |
CN102731328A (zh) | 一种盐酸安非他酮的制备方法 | |
CN102731315B (zh) | 一种n,n`二甲基环己二胺的生产方法 | |
CN105924400B (zh) | 阿齐沙坦杂质a和b的制备方法 | |
CN102464595A (zh) | 一种伊伐布雷定中间体的合成方法 | |
CN103030580A (zh) | 一种拉帕替尼中间体的制备方法 | |
US20160168161A1 (en) | Method for producing heterocyclic compound | |
CN103664647A (zh) | 2,3-二氨基-7-溴-9,9’-二烷基芴及其制备方法 | |
CN103073498A (zh) | (R)-α-氨基己内酰胺的制备新方法 | |
CN104628555B (zh) | 一种药物中间体4-(4-氯苯基)环己基-1-甲酸的合成方法 | |
CN102070428A (zh) | 一种合成3-羟基苯乙酮的方法 | |
CN100402508C (zh) | 烷氧基-(四唑-1-基)苯甲醛化合物及其生产方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 225200 No.86 Shuangshu Road, Xiannv Town, Jiangdu District, Yangzhou City, Jiangsu Province Patentee after: Tianhe Pharmaceutical Co.,Ltd. Address before: 225200 No. 86, Shuangshu Road, Xiannv Town, Jiangdu, Yangzhou City, Jiangsu Province Patentee before: YANGZHOU TIANHE PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of robbencoxib Effective date of registration: 20220129 Granted publication date: 20140205 Pledgee: Yangzhou Branch of Bank of Jiangsu Co.,Ltd. Pledgor: Tianhe Pharmaceutical Co.,Ltd. Registration number: Y2022980001363 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230328 Granted publication date: 20140205 Pledgee: Yangzhou Branch of Bank of Jiangsu Co.,Ltd. Pledgor: Tianhe Pharmaceutical Co.,Ltd. Registration number: Y2022980001363 |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 225200 No.86 Shuangshu Road, Xiannv Town, Jiangdu District, Yangzhou City, Jiangsu Province Patentee after: Tianhe Pharmaceutical Co.,Ltd. Country or region after: China Address before: 225200 No.86 Shuangshu Road, Xiannv Town, Jiangdu District, Yangzhou City, Jiangsu Province Patentee before: Tianhe Pharmaceutical Co.,Ltd. Country or region before: China |